A cytotoxic analysis of antiseptic medication on skin substitutes and autograft
Authors:
- 1 July 2007
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 157 (1) , 33-40
Abstract
There is an increasing demand for the clinical application of human skin substitutes (HSSs) for treating ulcers, burns and surgical wounds. Due to this increasing demand and due to the simultaneous requirement for the administration of topical antiseptic medications, there is a need to determine potential cytotoxic effects of these medications on HSSs compared with autograft skin. To perform such an evaluation. Two different HSSs were used (autologous reconstructed epidermis on fibroblast-populated human dermis and allogeneic reconstructed epidermis on a fibroblast-populated rat collagen gel) and were compared with conventional full-thickness autograft. Twelve different antiseptics were applied topically to the stratum corneum in vitro for 24 h. The degree of cytotoxicity was analysed as detrimental changes in histology, metabolic activity (MTT assay) and RNA staining of tissue sections. The antiseptic medications tested showed different degrees of cytotoxicity. Acticoat, Aquacel Ag, Dermacyn, Fucidin, 0.5% silver nitrate solution and chlorhexidine digluconate were not cytotoxic for either HSS or autograft, and can therefore be used as required. Flamazine and zinc oxide cream resulted in moderate cytotoxicity. However, application of Betadine((R)), cerium-silver sulfadiazine cream, silver sulfadiazine cream with 1% acetic acid and Furacine resulted in a substantial decrease in cell viability and a detrimental effect on tissue histology when applied to autograft and especially to HSS. Due to the potential cytotoxic effect of some antiseptics on HSS, it is advised that clinicians balance the cytotoxicity of the medication, its antiseptic properties and the severity of colonization in choosing which one to apply.Keywords
This publication has 18 references indexed in Scilit:
- Update on Tissue-Engineered Biological DressingsTissue Engineering, 2006
- Autologous full-thickness skin substitute for healing chronic woundsBritish Journal of Dermatology, 2006
- Visualisation of bacterial sequestration and bactericidal activity within hydrating Hydrofiber® wound dressingsBiomaterials, 2006
- Induction of cytokine (interleukin‐1α and tumor necrosis factor‐α) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposureExperimental Dermatology, 2005
- Inflammation and Wound Healing: The Role of Bacteria in the Immuno-Regulation of Wound HealingThe International Journal of Lower Extremity Wounds, 2004
- The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn woundsBurns, 2000
- Mutual induction of growth factor gene expression by epidermal-dermal cell interactionJournal of Cell Biology, 1993
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Living Tissue Formed in Vitro and Accepted as Skin-Equivalent Tissue of Full ThicknessScience, 1981
- Corticoids and Cultured Human Epidermal Keratinocytes: Specific Intracellular Binding and Clinical EfficacyJournal of Investigative Dermatology, 1981